A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components

Clinical trial NCT00819104 · COMPLETED

Trial details

NCT number: NCT00819104
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Hypertension

Start date: 2008-11-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.